News in the Life Sciences Industry

NEW YORK, Dec. 20, 2018 /PRNewswire/ -- S1 Biopharma, Inc. (S1) announced today that the European Patent Office has granted a European Patent for the Company's proprietary dual-mechanistic therapy Lorexys(TM) for hypoactive sexual desire disorder. A corresponding patent was previously... Read more ››

BEIJING, Dec. 20, 2018 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced... Read more ››

BEIJING, Dec. 19, 2018 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, announced a... Read more ››

SEONGNAM, South Korea, Dec. 18, 2018 /PRNewswire/ -- Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, announced that the company signed a license agreement with Daewoong Pharmaceutical Co., Ltd. for development of BBT-401, the first anti-Pellino-1... Read more ››

DUBLIN, Dec. 17, 2018 /PRNewswire/ -- A little over a year after raising over EUR 28 million in a private placement, Q3 Medical Devices Limited ("Q3 Medical" or the "Company") based in Dublin, Ireland today announced a new initiative to raise EUR 50 million in a Pre-IPO round that will prepare... Read more ››

SEONGNAM, South Korea, Dec. 16, 2018 /PRNewswire/ -- Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea and a tenant company of JLABS@TMC in Houston, Texas, announced that the Investigational New Drug (IND) application for BBT-877, a potent best-in-class... Read more ››